Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Federico

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Journal of Virology|December 10, 1999
cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tailsE Olivetta, K Pugliese, R Bona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2018
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upD A Eichenauer, B M P Aleman, M André, et al.
Leukemia & Lymphoma|August 1, 1994
Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL)G Capnist, M Federico, T Chisesi, et al.
British Journal of Haematology|May 1, 1989
Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell LeukemiaM Federico, T Chisesi, F Lauria, et al.
International Journal of Cancer|November 15, 1986
Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factorI Gresser, F Belardelli, J Tavernier, et al.
AIDS Research|January 1, 1986
Transplacental transmission of HTLV-III virusB Macchi, M Federico, A Orecchia, et al.
Haematologica|May 9, 1998
Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei LinfomiF Merli, M Federico, P Avanzini, et al.
Breast Cancer Research and Treatment|August 6, 2002
Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body compositionG Del Rio, S Zironi, L Valeriani, et al.
Acta Haematologica|January 1, 1989
Increasing interdependency of prognosis- and therapy-related factors in Hodgkin's diseaseP G Gobbi, C Cavalli, M Federico, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Journal of Virology|December 10, 1999
cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tailsE Olivetta, K Pugliese, R Bona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2018
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upD A Eichenauer, B M P Aleman, M André, et al.
Leukemia & Lymphoma|August 1, 1994
Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL)G Capnist, M Federico, T Chisesi, et al.
British Journal of Haematology|May 1, 1989
Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell LeukemiaM Federico, T Chisesi, F Lauria, et al.
International Journal of Cancer|November 15, 1986
Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factorI Gresser, F Belardelli, J Tavernier, et al.
AIDS Research|January 1, 1986
Transplacental transmission of HTLV-III virusB Macchi, M Federico, A Orecchia, et al.
Haematologica|May 9, 1998
Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei LinfomiF Merli, M Federico, P Avanzini, et al.
Breast Cancer Research and Treatment|August 6, 2002
Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body compositionG Del Rio, S Zironi, L Valeriani, et al.
Acta Haematologica|January 1, 1989
Increasing interdependency of prognosis- and therapy-related factors in Hodgkin's diseaseP G Gobbi, C Cavalli, M Federico, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Pageof 26